GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

Show other versions (1)

Therapy-related myeloid neoplasm (t-MN) is a distinctive clinical syndrome occurring after exposure to chemotherapy or radiotherapy. t-MN arises in most cases from a multipotential hematopoietic stem cell or, less commonly, in a lineage committed progenitor cell. The prognosis for patients with t-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-05-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	therapy-related myeloid neoplasms, genetic pathways, cytogenetic abnormalities, del(5q)
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/287
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Rachel Bergerson, et al.
Published: (2011-01-01)

Optimization criteria for ordering myeloid neoplasm next‐generation sequencing
by: Savanah D. Gisriel, et al.
Published: (2024-12-01)

Infant acute myeloid leukemia: insights into the biology and therapy
by: Xiaoli Chen, et al.
Published: (2024-12-01)

Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran
by: Mahshid Heidary Sadegh, et al.
Published: (2025-01-01)

Novel additional cytogenetic abnormalities associated with Philadelphia chromosome
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01)

Cytogenetic profile and risk of transformation to acute myeloid leukemia (AML) in Indonesian patients with myelodysplastic syndrome (MDS): a pilot study [version 1; peer review: 2 approved]
by: Yuniar Harris Prayitno, et al.
Published: (2024-03-01)

Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
by: Ibrahim C. Haznedaroglu
Published: (2014-08-01)

Central Diabetes Insipidus in Acute Myeloid Leukemia with Cytogenetic Abnormality of 9q34 Deletion
by: Majd Farajallah, et al.
Published: (2024-07-01)

Acute Myeloid Leukemia with Normal Cytogenetics and <i>NPM1</i>-Mutation: Impact of Mutation Topography on Outcomes
by: Mingyue Zhao, et al.
Published: (2024-12-01)

Structural and functional alterations in hematological parameters among individuals at clinically high risk for acute lymphocytic leukemia
by: Mohd Afzal, et al.
Published: (2024-12-01)

Light-chain amyloidosis with concomitant symptomatic myeloma (CRAB-SLiM features): clinical characteristics, cytogenetic abnormalities, and outcomes
by: Chenqi Yu, et al.
Published: (2024-11-01)

Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis
by: Hakan Keski, et al.
Published: (2024-12-01)

Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024-09-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
by: Ercole Brusamolino, et al.
Published: (2014-08-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES.
by: Gabriele Magliano, et al.
Published: (2020-10-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Myelodysplastic Neoplasm with Complex Karyotype and ETV6 Variant: Challenges in Treatment
by: Elaiza Almeida Antônio de Kós, et al.
Published: (2024-04-01)

Prenatal Cytogenetic Findings in 13.466 Cases of High-Risk Pregnant Women in One Laboratory
by: Leyla Özer, et al.
Published: (2013-12-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms
by: Qiang Ma, et al.
Published: (2024-12-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-05-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Raffaella Marcheselli, et al.
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Alessia Bari, et al.
Published: (2011-12-01)

CLINICO-PATHOLOGICAL SPECTRUM AND NOVEL KARYOTYPIC FINDINGS IN MYELODYSPLASTIC SYNDROME: EXPERIENCE OF TERTIARY CARE CENTRE IN INDIA.
by: Ruchi Gupta, et al.
Published: (2017-08-01)

Pathological and compensatory reactions in the blood system of small rodents exposed to chronic low dose ionizing radiation
by: A. I. Lypska, et al.
Published: (2024-12-01)

Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2025-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
by: Ercole Brusamolino, et al.
Published: (2014-08-01)

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM
by: Richard A. Larson, et al.
Published: (2011-07-01)

MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER
by: Paola Ranalli, et al.
Published: (2024-08-01)

Monocephalus dipygus in a 4-month-old mixed-breed puppy: clinical, radiographic, ultrasonographic, karyotyping and surgical intervention
by: Lorena Elizabeth Chalco-Torres, et al.
Published: (2024-12-01)

Karyotype features based on diploid number and sex chromosome system of Steatoda grossa (Araneae: Theridiidae) from Turkey
by: Zübeyde Kumbıçak
Published: (2019-12-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

Identification of univalent chromosomes in monosomic lines of cotton (Gossypium hirsutum L.) by means of cytogenetic markers
by: M. F. Sanamyan, et al.
Published: (2019-11-01)

The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study
by: Dong Liang, et al.
Published: (2024-12-01)

Acute Myeloid Leukemia Presenting as a Cardiac Mass
by: Alia Magzoub Mohamed, et al.
Published: (2020-11-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Lisa Pieri, et al.
Published: (2010-06-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
by: Yoko Edahiro, et al.
Published: (2024-12-01)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
by: Julie Schanz, et al.
Published: (2015-04-01)

Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker
by: Fadul A, et al.
Published: (2024-12-01)